Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra

OBJECTIVES: To investigate real-world short-term outcomes among patients with systemic JIA starting tocilizumab or anakinra. METHODS: This analysis included all systemic JIA patients within the UK Biologics for Children with Rheumatic Diseases study starting tocilizumab or anakinra between 2010 and...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Rheumatology (Oxford)
Auteurs principaux: Kearsley-Fleet, Lianne, Beresford, Michael W, Davies, Rebecca, De Cock, Diederik, Baildam, Eileen, Foster, Helen E, Southwood, Taunton R, Thomson, Wendy, Hyrich, Kimme L
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2019
Sujets:
Clinical Science
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6293481/
https://ncbi.nlm.nih.gov/pubmed/30137641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/key262
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires